The coronavirus disease 2019 (COVID-19) is our latest pandemic, preceded by the H1N1
swine flu in 2009, which lasted approximately 19 months. One of the special characteristics …

Earlier variants of SARS-CoV-2 have been associated with hypercoagulability and an
extensive formation of fibrin amyloid microclots, which are considered to contribute to the …

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent
history of humankind, afflicting more than 27 million individuals to date. While the majority of …

Objectives Thrombin generation (TG) with and without thrombomodulin (TM) was evaluated
in COVID-19 patients with different disease severity and thromboprophylaxis regimen, in …

An important component of severe COVID-19 disease is virus-induced endothelilitis. This
leads to disruption of normal endothelial function, initiating a state of failing normal clotting …

Background: Numerous tools, including inflammatory biomarkers and lung injury severity
scores, have been evaluated as predictors of thromboembolic events and the requirement …

Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …

Introduction Coagulation dysfunction and thromboembolism emerge as strong comorbidity
factors in severe COVID‐19. However, it is unclear when particularly platelet activation …

Clinical manifestations of COVID-19 include symptoms of vertigo and dizziness, which is
rather unsurprising, since SARS-CoV-2 neurotropism may inflict a broad spectrum of …